Professor, Internal Medicine, Virginia Commonwealth University, Medical College of Virginia School of Medicine
Nephrology
Dr. Todd W. Gehr, MD
|
|
Give Review
Doctor Todd W. Gehr, MD works in the field of Nephrology. He attended SUNY Upstate Medical University. He has 2 awards "Regional Top Doctor" and "Top MD". Todd Gehr is a published physician as well. He has 90 publications published. The latest was: Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Todd Gehr accepts Medicare payments and is registered with Medicare.gov.
Publications
- Differences in coagulation in clotting of vascular access in hemodialysis patients.
- DIFFERENCES IN COAGULATION BETWEEN HEMODIALYSIS AND PERITONEAL DIALYSIS.
- NADPH Oxidase-Mediated Triggering of Inflammasome Activation in Mouse Podocytes and Glomeruli during Hyperhomocysteinemia.
- Renal function, fitness, and mortality in women.
- Pretransplant transcriptome profiles identify among Kidneys with delayed graft function those with poorer quality and outcome.
- Curcumin prevents cardiac remodeling secondary to chronic renal Failure through deactivation of hypertrophic signaling in rats.
- A hypothesis-generating study to evaluate platelet activity in diabetics with chronic Kidney disease.
- Current Concepts of Pharmacotherapy in Hypertension - ACE Inhibitors: Current Considerations in Their Use.
- Current Concepts of Pharmacotherapy in Hypertension: Clinical Implications of the Dose Response Relationship of Antihypertensive Medication in the Treatment of Hyperte...
- Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients wi...
- The pharmacokinetics of losartan in Renal insufficiency.
- Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal Disease.
- Curcumin ameliorates renal Failure in 5/6 nephrectomized rats: role of inflammation.
- Curcumin and enalapril ameliorates renal Failure by antagonizing inflammation in 5/6 nephrectomized rats: Role of phospholipase and cyclooxygenase.
- Direct vasodilators and their role in Hypertension management: minoxidil.
- The pharmacokinetics of subcutaneous enoxaparin in end-stage renal Disease.
- Disposition and safety of omapatrilat in subjects With renal impairment.
- Cost-effectiveness of sevelamer versus Calcium carbonate plus atorvastatin to reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosph...
- Chronically increased intra-abdominal pressure produces systemic hypertension in dogs.
- Pharmacokinetics and blood pressure response of losartan in end-stage renal Disease.
- Risk-benefit ratio of angiotensin antagonists versus ACE inhibitors in end-stage renal Disease.
- Replacement of amino acid and protein losses With 1.1% amino acid peritoneal dialysis solution.
- Simple high-performance liquid chromatographic method for determination of losartan and E-3174 metabolite in human plasma, urine and dialysate.
- The pharmacokinetics of irbesartan in renal Failure and maintenance hemodialysis.
- The pharmacokinetics of pravastatin in patients on Chronic hemodialysis.
- The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis.
- Effect of increased Renal venous pressure on Renal function.
- The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients With hypertension and renal insufficiency.
- Novel high-performance liquid chromatographic method using solid-phase on-line elution for determination of metolazone in plasma and whole blood.
- The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone.
- The peritoneal equilibration test in children.
- The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
- The pharmacodynamics of intravenous and oral torsemide in patients with Chronic renal insufficiency.
- The pharmacokinetics of intravenous and oral torsemide in patients with Chronic renal insufficiency.
- Catheter-related Mycobacterium chelonei infection in a CAPD patient.
- Hormonal, blood pressure, and peritoneal transport Response to short-term ACE inhibition.
- Case report and review of the literature: ureteral endometriosis.
- Furosemide pharmacokinetics and pharmacodynamics in Renal transplantation.
- Triamterene and the Kidney.
- Quantitation of metolazone in urine by high-performance liquid chromatography With fluorescence detection.
- Metolazone pharmacokinetics and pharmacodynamics in Renal transplantation.
- Fosinopril pharmacokinetics and pharmacodynamics in Chronic ambulatory peritoneal dialysis patients.
- External-standard high-performance liquid chromatographic method for quantitative determination of furosemide in plasma by using solid-phase extraction and on-line elu...
- New hydrophilic copolymers for biomedical applications.
- Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.
- Pharmacokinetics of sematilide in renal Failure.
- Colloid infusions reduce glomerular filtration in resuscitated burn victims.
- Pharmacokinetics and pharmacodynamics of torasemide in patients with Chronic renal insufficiency--preliminary evaluation.
- Diuretics in congestive heart Failure.
- Treatment of malnutrition With 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study.
- Renal transplantation in adults With thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome.
- Effects of increased Renal parenchymal pressure on Renal function.
- Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers.
- A prospective study of vascular access infections at seven outpatient hemodialysis centers.
- MicroRNA profiles in allograft tissues and paired urines associate with Chronic allograft dysfunction with IF/TA.
- Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system.
- Progressive skin fibrosis.
- An in vivo-in vitro study of cefepime and cefazolin dialytic clearance during high-flux hemodialysis.
- High prevalence of vitamin D deficiency in African American Kidney transplant recipients.
- Use of diuretics in the treatment of heart Failure in the elderly.
- Effects of salicylic acid on post-ischaemic ventricular function and purine efflux in isolated mouse Hearts.
- An HPLC method for determination of inosine and hypoxanthine in human plasma from healthy volunteers and patients presenting with potential Acute cardiac ischemia.
- The pharmacokinetics of enoxaparin do not correlate With its pharmacodynamic effect in patients receiving dialysis therapies.
- Desmopressin : safety considerations in patients with Chronic renal disease.
- Enhanced anticoagulant activity of enoxaparin in patients With ESRD as measured by thrombin generation time.
- Aldosterone-receptor antagonism and end-stage renal Disease.
- Liquid chromatography method for determination of bivalirudin in human plasma and urine using automated ortho-phthalaldehyde derivatization and fluorescence detection.
- Improving adequacy of peritoneal dialysis in ESRD Network 5 (Maryland; Washington, DC; Virginia; West Virginia).
- Hyperkalemia, congestive heart Failure, and aldosterone receptor antagonism.
- Diuretic use in stage 5 chronic Kidney disease and end-stage renal disease.
- PPARgamma ligand attenuates PDGF-induced mesangial cell proliferation: role of MAP kinase.
- Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerations.
- The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal Disease.
- The role of the renin-angiotensin system in cholesterol and puromycin mediated Renal injury.
- Calcineurin inhibitor-induced Chronic nephrotoxicity in liver transplant patients is reversible using rapamycin as the primary immunosuppressive agent.
- Pharmacokinetics of icodextrin in peritoneal dialysis patients.
- 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and rhabdomyolysis: considerations in the renal Failure patient.
- Rhabdomyolysis and statin therapy: relevance to the elderly.
- Effect of timing of dialysis on mortality in critically ill, septic patients with Acute renal failure.
- A rapid and simple chemiluminescence method for screening levels of inosine and hypoxanthine in non-traumatic chest pain patients.
- The financial implications for Medicare of greater use of peritoneal dialysis.
- A pilot study of genetic polymorphisms and hemodialysis vascular access thrombosis.
- Simple HPLC-UV method for determination of iohexol, iothalamate, p-aminohippuric acid and n-acetyl-p-aminohippuric acid in human plasma and urine With ERPF, GFR and ER...
- Clinical pharmacokinetics of losartan.
- Gene expression changes are associated with loss of Kidney graft function and interstitial fibrosis and tubular atrophy: diagnosis versus prediction.
- A simple and sensitive HPLC fluorescence method for determination of tadalafil in mouse plasma.
- Chronic Kidney disease: detection and evaluation.
- Superiority of icodextrin compared With 4.25% dextrose for peritoneal ultrafiltration.
- Characterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice.
Schools
West Virginia University School Of Medicine
Med College Of Virginia Hospital
University Hospital SUNY Health Science Center
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Alkalosis
- Calcium Metabolism Disorders
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Regional Top Doctor
- Top MD
Education
-
Virginia Commonwealth University Health System -
SUNY Upstate Medical University -
West Virginia University School of Medicine
Drug Facts
| NPI NUMBER | 1487738233 | |
| NPPES Provider LastName | GEHR | |
| NPPES Provider FirstName | TODD | |
| NPPES Provider ZIPCode | 232985051 | |
| NPPES Provider State | VA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1316.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 111.0 | |
| Percent Opioid Claims | 8.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487738233 |
| Last Name Of The Provider | GEHR |
| First Name Of The Provider | TODD |
| View All |
Similar Doctors
|
|
Dr. Ellen G. Bedichek, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia R. Nunley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne L. King, MD |
|
|
Dr. Mauricio R. Monrroy, MD |
|
|
Dr. Chudamani K. Rao, MD |
|
|
Dr. Shreyank Tripathi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haidr S. Agha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irvin N. Sporn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Li Yang, MD |